Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. Read more about Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Read more about Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade. Read more about Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Read more about Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. Read more about Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Read more about New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
Cancer health disparities in racial/ethnic minorities in the United States. Read more about Cancer health disparities in racial/ethnic minorities in the United States.
Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper. Read more about Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. Read more about Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Response to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study". Read more about Response to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study".
